BioVersys

About BioVersys

BioVersys is a Basel-based biopharmaceutical company focused on researching and developing small-molecule therapies to combat antimicrobial resistance and tuberculosis. The privately held Swiss firm targets major infectious disease challenges by innovative modes of action and novel targets, aiming to improve patient outcomes and address resistant infections. Its pipeline includes products in lead optimization, preclinical, and clinical stages with collaborations and a global footprint in the AMR and TB fields.